Home Diagnostics PHASE Scientific Americas markets INDICAID health at-home test kits with a CLIA certified and CAP accredited lab, presenting a ready-to-sell at-home health testing platform that can be offered directly to consumers or bundled with telehealth services.

Expansion Momentum Recent launches of two at-home collection kits and Respiratory Health 3 indicate rapid product cadence and a push into broader at-home diagnostics, suggesting opportunities to upsell complementary tests, lab processing, and digital health experiences.

Clinical Partnerships Existing collaboration with telehealth provider Dr. B signals openness to distribution partnerships and bundled care solutions; sales teams can explore additional healthcare networks, insurers, and employer programs to scale INDICAID health.

Growth Alignment Being recognized as a Deloitte Hong Kong Technology Fast Leader and operating a growing global footprint implies readiness for enterprise-grade partnerships, channel partnerships, and OEM/white-label opportunities with larger biotech and healthcare players.

Funding & Capability Revenue in the mid-range of tens of millions and an in-house CLIA/CAP certified lab position PHASE Scientific Americas as a credible partner for contract diagnostics, clinical studies, and rapid deployment of new at-home test offerings.